Home LiteratureArticle Details
PMID: 9518498 Published · ppublish English Journal Article

Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.

Nucleic acids research ·Vol. 26 ·No. 8 ·1998-04-15 ·Pages 2016-23

Marcusson EG, Bhat B, Manoharan M, Bennett CF, Dean NM

Abstract

Antisense oligonucleotides complementary to specific mRNA sequences are widely used inhibitors of gene expression in vitro and in vivo . In vitro cationic lipids have been demonstrated to increase the pharmacological activity of antisense oligonucleotides by increasing cellular uptake and facilitating nuclear accumulation. We have investigated the intracellular fate of oligonucleotide/cationic lipid complexes using fluorescently labeled lipids and oligonucleotides targeted to protein kinase C-alpha. After addition to cells the lipids initially co-localized with the oligonucleotide on the cell surface and in fine punctate structures within the cytoplasm. At later times the oligonucleotide began to accumulate in the nucleus as well as the cytoplasm. In contrast, the cationic lipid remained localized to the cell surface and the cytoplasm and was never found in the nucleus. Expression of protein kinase C-alpha mRNA did not begin to decline until after oligonucleotide was seen in the nucleus. This was also coincident with the transient appearance of a smaller mRNA transcript believed to result from RNase H cleavage of protein kinase C-alpha mRNA. These data suggest that although cationic lipids facilitate uptake of oligonucleotides, the complex must disassociate before the oligonucleotide can gain access to the nucleus and induce degradation of targeted mRNA.

MeSH Terms
Boron Compounds/chemical synthesis,chemistry Cell Nucleus/metabolism Drug Carriers Fatty Acids, Monounsaturated/chemistry,pharmacokinetics Fluorescent Dyes Humans Isoenzymes/biosynthesis,genetics Kinetics Lung Neoplasms Molecular Structure Oligonucleotides, Antisense/administration & dosage,pharmacokinetics,pharmacology Protein Kinase C/biosynthesis,genetics Protein Kinase C-alpha Quaternary Ammonium Compounds/chemical synthesis,chemistry,pharmacokinetics RNA, Messenger/biosynthesis Thionucleotides Transcription, Genetic/drug effects Tumor Cells, Cultured
Chemicals
1-O-oleoyl-2-((BODIPY)-dodecanoyl)-N,N,N-trimethyl-3-aminopropane bromide Boron Compounds Drug Carriers Fatty Acids, Monounsaturated Fluorescent Dyes Isoenzymes Oligonucleotides, Antisense Quaternary Ammonium Compounds RNA, Messenger Thionucleotides PRKCA protein, human Protein Kinase C Protein Kinase C-alpha 1,2-dioleoyloxy-3-(trimethylammonium)propane
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Marcusson E G
Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008, USA.
Bhat B
Manoharan M
Bennett C F
Dean N M
References (56)
56 references, click to expand
  1. Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme).
    Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):177-85 PMID: 9212908
  2. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3318-22 PMID: 7724560
  3. In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.
    Nucleic Acids Res. 1997 Aug 15;25(16):3290-6 PMID: 9241243
  4. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
    Lab Invest. 1997 Oct;77(4):379-88 PMID: 9354772
  5. Biosynthesis in vitro of fucose-containing glycosphingolipids in human neuroblastoma IMR-32 cells.
    Proc Natl Acad Sci U S A. 1978 Jan;75(1):289-93 PMID: 272643
  6. Characterization of oligonucleotide transport into living cells.
    Proc Natl Acad Sci U S A. 1989 May;86(10):3474-8 PMID: 2726730
  7. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6454-8 PMID: 2549537
  8. Intracellular distribution of microinjected antisense oligonucleotides.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2702-6 PMID: 1849273
  9. Rapid nuclear accumulation of injected oligodeoxyribonucleotides.
    New Biol. 1990 Dec;2(12):1091-100 PMID: 1708281
  10. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.
    Bioconjug Chem. 1990 Mar-Apr;1(2):149-53 PMID: 1965625
  11. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7595-9 PMID: 1881900
  12. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
    J Biol Chem. 1991 Sep 25;266(27):18162-71 PMID: 1680858
  13. Binding of oligonucleotides to cell membranes at acidic pH.
    Biochem Biophys Res Commun. 1991 Dec 31;181(3):1343-51 PMID: 1764085
  14. The uptake kinetics of chimeric oligodeoxynucleotide analogues in human leukaemia MOLT-4 cells.
    Anticancer Drug Des. 1992 Apr;7(2):115-29 PMID: 1575885
  15. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
    Mol Pharmacol. 1992 Jun;41(6):1023-33 PMID: 1352033
  16. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides.
    J Biol Chem. 1992 Jun 25;267(18):12436-9 PMID: 1618751
  17. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
    Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301 PMID: 7638184
  18. Cellular and molecular barriers to gene transfer by a cationic lipid.
    J Biol Chem. 1995 Aug 11;270(32):18997-9007 PMID: 7642560
  19. The therapeutic potential of antisense oligonucleotides.
    Bioessays. 1995 Dec;17(12):1055-63 PMID: 8634067
  20. Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates.
    Pharm Res. 1995 Oct;12(10):1548-53 PMID: 8584498
  21. Novel polyaminolipids enhance the cellular uptake of oligonucleotides.
    J Biol Chem. 1995 Dec 29;270(52):31391-6 PMID: 8537413
  22. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
    Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3176-81 PMID: 8622909
  23. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.
    Nucleic Acids Res. 1996 Jun 1;24(11):2176-82 PMID: 8668551
  24. Progress in antisense oligonucleotide therapeutics.
    Annu Rev Pharmacol Toxicol. 1996;36:107-29 PMID: 8725384
  25. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.
    Pharm Res. 1996 Mar;13(3):404-10 PMID: 8692733
  26. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
    Mol Pharmacol. 1996 Aug;50(2):236-42 PMID: 8700129
  27. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Cancer Res. 1996 Aug 1;56(15):3499-507 PMID: 8758918
  28. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.
    J Pharmacol Exp Ther. 1996 Sep;278(3):1362-72 PMID: 8819524
  29. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Mol Pharmacol. 1996 Oct;50(4):808-19 PMID: 8863825
  30. Mechanism of oligonucleotide release from cationic liposomes.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11493-8 PMID: 8876163
  31. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
    Pharm Res. 1996 Sep;13(9):1367-72 PMID: 8893276
  32. Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.
    Mol Pharmacol. 1996 Dec;50(6):1487-94 PMID: 8967969
  33. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.
    Leuk Res. 1996 Nov-Dec;20(11-12):925-30 PMID: 9009250
  34. Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides.
    Antisense Nucleic Acid Drug Dev. 1996 Winter;6(4):291-9 PMID: 9012865
  35. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.
    Biochemistry. 1997 Mar 11;36(10):3008-17 PMID: 9062132
  36. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery.
    J Pharm Sci. 1997 Jun;86(6):762-4 PMID: 9188063
  37. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7031-5 PMID: 1495997
  38. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
    Nature. 1992 Sep 3;359(6390):67-70 PMID: 1522889
  39. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
    Exp Cell Res. 1992 Oct;202(2):391-7 PMID: 1397092
  40. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
    J Biol Chem. 1992 Oct 5;267(28):19954-62 PMID: 1400312
  41. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker.
    Antisense Res Dev. 1992 Spring;2(1):17-25 PMID: 1422083
  42. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes.
    Pharm Res. 1992 Oct;9(10):1235-42 PMID: 1448419
  43. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.
    Nucleic Acids Res. 1992 Nov 11;20(21):5691-8 PMID: 1454532
  44. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.
    Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1048-52 PMID: 8430072
  45. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides.
    Biochem Biophys Res Commun. 1993 Feb 15;190(3):952-60 PMID: 8094959
  46. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
    Antisense Res Dev. 1993 Spring;3(1):53-66 PMID: 8495106
  47. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
    Nucleic Acids Res. 1993 Jul 25;21(15):3567-73 PMID: 8346033
  48. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    J Pharmacol Exp Ther. 1993 Dec;267(3):1181-90 PMID: 8166890
  49. The kinetic aspects of intracellular fluorescence labeling with TMA-DPH support the maturation model for endocytosis in L929 cells.
    J Cell Biol. 1994 May;125(4):783-94 PMID: 8188746
  50. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
    J Biol Chem. 1994 Jun 10;269(23):16416-24 PMID: 7911467
  51. Gene inhibition using antisense oligodeoxynucleotides.
    Nature. 1994 Nov 24;372(6504):333-5 PMID: 7969490
  52. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.
    Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11762-6 PMID: 7972137
  53. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
    Nucleic Acids Res. 1994 Nov 11;22(22):4681-8 PMID: 7984418
  54. Functions and structures of ribonuclease H enzymes.
    Subcell Biochem. 1995;24:377-422 PMID: 7900182
  55. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
    J Clin Invest. 1995 Apr;95(4):1814-23 PMID: 7706488
  56. Developing oligonucleotide therapeutics for human leukemia.
    Anticancer Drug Des. 1997 Jul;12(5):341-58 PMID: 9236851
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
0305-1048
Published
1998-04-15
Pages
2016-23
Language
English
Region
England
NLM ID
0411011
PMCID
PMC147486
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com